title: Oxadiazole-isopropylamides as potent and noncovalent proteasome inhibitors.
abstract: Screening of the 50000 ChemBridge compound library led to the identification of the oxadiazole-isopropylamide 1 (PI-1833) which inhibited chymotrypsin-like (CT-L) activity (IC50 = 0.60 μM) with little effects on the other two major proteasome proteolytic activities, trypsin-like (T-L) and postglutamyl-peptide-hydrolysis-like (PGPH-L). LC-MS/MS and dialysis show that 1 is a noncovalent and rapidly reversible CT-L inhibitor. Focused library synthesis provided 11ad (PI-1840) with CT-L activity (IC50 = 27 nM). Detailed SAR studies indicate that the amide moiety and the two phenyl rings are sensitive toward modifications. Hydrophobic residues, such as propyl or butyl in the para position (not ortho or meta) of the A-ring and a m-pyridyl group as B-ring, significantly improve activity. Compound 11ad (IC50 = 0.37 μM) is more potent than 1 (IC50 = 3.5 μM) at inhibiting CT-L activity in intact MDA-MB-468 human breast cancer cells and inhibiting their survival. The activity of 11ad warrants further preclinical investigation of this class as noncovalent proteasome inhibitors.
authors.affiliation: Drug Discovery Department, Moffitt Cancer Center , 12902 Magnolia Drive, Tampa, Florida 33612, USA.
authors.forename: Sevil
authors.initials: S
authors.lastname: Ozcan
authors.forename: Aslamuzzaman
authors.initials: A
authors.lastname: Kazi
authors.forename: Frank
authors.initials: F
authors.lastname: Marsilio
authors.forename: Bin
authors.initials: B
authors.lastname: Fang
authors.forename: Wayne C
authors.initials: WC
authors.lastname: Guida
authors.forename: John
authors.initials: J
authors.lastname: Koomen
authors.forename: Harshani R
authors.initials: HR
authors.lastname: Lawrence
authors.forename: Saïd M
authors.initials: SM
authors.lastname: Sebti
mesh_terms: D000111:Acetylcysteine / Q000031:analogs & derivatives / Q000494:pharmacology; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D004354:Drug Screening Assays, Antitumor; D057166:High-Throughput Screening Assays; D006801:Humans; D007202:Indicators and Reagents; D013058:Mass Spectrometry; D010069:Oxadiazoles / Q000138:chemical synthesis* / Q000494:pharmacology*; D061988:Proteasome Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D014357:Trypsin / Q000378:metabolism
chemical_list: D015853:Cysteine Proteinase Inhibitors; D007202:Indicators and Reagents; D010069:Oxadiazoles; D061988:Proteasome Inhibitors; C067713:lactacystin; D002918:Chymotrypsin; D014357:Trypsin; D000111:Acetylcysteine
references.citation: J Med Chem. 2004 Sep 23;47(20):4810-3
references.pmid: 15369383
references.citation: Blood. 2008 Mar 1;111(5):2765-75
references.pmid: 18057228
references.citation: Bioorg Med Chem Lett. 2002 May 20;12(10):1331-4
references.pmid: 11992770
references.citation: Cell. 1998 Feb 6;92(3):367-80
references.pmid: 9476896
references.citation: Chem Rev. 2007 Mar;107(3):687-717
references.pmid: 17316053
references.citation: J Biol Chem. 2003 Jun 13;278(24):21517-25
references.pmid: 12676932
references.citation: J Med Chem. 2001 May 10;44(10):1560-3
references.pmid: 11334565
references.citation: Curr Top Med Chem. 2010;10(3):232-56
references.pmid: 20166955
references.citation: J Med Chem. 2012 Mar 8;55(5):1978-98
references.pmid: 22220566
references.citation: Eur J Med Chem. 2011 Jul;46(7):3000-12
references.pmid: 21549456
references.citation: Structure. 2006 Mar;14(3):451-6
references.pmid: 16531229
references.citation: Expert Opin Investig Drugs. 2008 Jun;17(6):879-95
references.pmid: 18491989
references.citation: Eur J Med Chem. 2012 Jun;52:322-7
references.pmid: 22440858
references.citation: Cell. 1994 Oct 7;79(1):13-21
references.pmid: 7923371
references.citation: ChemMedChem. 2010 Oct 4;5(10):1701-5
references.pmid: 20715286
references.citation: J Med Chem. 2009 May 14;52(9):3028-38
references.pmid: 19348473
references.citation: Bioorg Med Chem. 2010 Aug 1;18(15):5576-92
references.pmid: 20621484
references.citation: Biochem J. 2010 Sep 15;430(3):461-76
references.pmid: 20632995
references.citation: J Am Chem Soc. 2006 Apr 19;128(15):5136-41
references.pmid: 16608349
references.citation: J Am Soc Mass Spectrom. 1994 Nov;5(11):976-89
references.pmid: 24226387
references.citation: Drug Discov Today. 2010 Mar;15(5-6):243-9
references.pmid: 20116451
references.citation: Bioorg Med Chem Lett. 2012 Apr 15;22(8):2744-7
references.pmid: 22437110
references.citation: Bioorg Med Chem Lett. 2009 Jan 1;19(1):83-6
references.pmid: 19041239
references.citation: J Org Chem. 2009 Nov 6;74(21):8181-90
references.pmid: 19817398
references.citation: Biochim Biophys Acta. 2004 Nov 29;1695(1-3):33-44
references.pmid: 15571807
references.citation: J Mol Biol. 2001 Aug 17;311(3):543-8
references.pmid: 11493007
references.citation: Chembiochem. 2004 Sep 6;5(9):1256-66
references.pmid: 15368577
references.citation: Chem Biol. 2001 Aug;8(8):739-58
references.pmid: 11514224
references.citation: J Biol Chem. 1999 Dec 10;274(50):35734-40
references.pmid: 10585454
references.citation: Annu Rev Biochem. 1996;65:801-47
references.pmid: 8811196
references.citation: Bioorg Med Chem Lett. 2006 Jun 15;16(12):3277-81
references.pmid: 16630721
references.citation: Chem Commun (Camb). 2008 Dec 7;(45):5981-3
references.pmid: 19030559
references.citation: J Cell Biochem Suppl. 2000;34:40-51
references.pmid: 10762014
references.citation: Curr Opin Cell Biol. 2004 Dec;16(6):623-8
references.pmid: 15530772
references.citation: J Med Chem. 2009 Sep 10;52(17):5420-8
references.pmid: 19678642
references.citation: J Biol Chem. 1998 Apr 10;273(15):8545-8
references.pmid: 9535824
references.citation: Curr Opin Cell Biol. 1995 Apr;7(2):215-23
references.pmid: 7612274
references.citation: Cancer Res. 2010 Mar 1;70(5):1970-80
references.pmid: 20160034
references.citation: J Med Chem. 2010 Jan 14;53(1):509-13
references.pmid: 19919035
references.citation: Bioorg Med Chem Lett. 2010 Nov 15;20(22):6581-6
references.pmid: 20875739
references.citation: Angew Chem Int Ed Engl. 2012 Jan 2;51(1):247-9
references.pmid: 22105886
references.citation: Science. 1995 May 5;268(5211):726-31
references.pmid: 7732382
references.citation: Nature. 1997 Apr 3;386(6624):463-71
references.pmid: 9087403
references.citation: J Biol Chem. 1997 Jan 3;272(1):182-8
references.pmid: 8995245
references.citation: J Med Chem. 2008 Feb 28;51(4):1068-72
references.pmid: 18247547
references.citation: J Org Chem. 2000 Feb 25;65(4):990-5
references.pmid: 10814045
references.citation: J Med Chem. 2011 Apr 28;54(8):2529-91
references.pmid: 21413808
references.citation: J Org Chem. 2003 Nov 14;68(23):9061-9
references.pmid: 14604381